Invasive fungal infections are an important cause of morbidity and mortality in hospitalized patients and in the immunocompromised population. This article reviews the current epidemiology of nosocomial fungal infections in adult patients, with an emphasis on invasive candidiasis and aspergillosis. Recently published recommendations and guidelines for the control and prevention of these nosocomial fungal infections are summarized in this article
Recently, the prevalence of invasive fungal infections (IFIs) is rising. The global mortality rate o...
Patient characteristics, antifungal prophylaxis, and other factors appear to have contributed to a c...
The incidence of fungal infections has been increasing for the last 3 decades, especially among neut...
Most fungal infections are common in humans. Pathogenic fungi are opportunistic but can cause fungal...
The aim of this article is to review the current recommendations for the diagnosis and treatment of ...
OBJECTIVE: To describe the incidence and patterns of nosocomial fungal infection in a large teaching...
The steady world-wide increase in the number of severely immunocompromised patients in most hospital...
Introduction: Nosocomial infections due to Candida show significant mortality and morbidity in recen...
Invasive fungus infection affects about six people out of every 100,000 people each year. Only half ...
Invasive fungus infection affects about six people out of every 100,000 people each year. Only half ...
Candidemia and invasive candidiasis are major causes of morbidity and mortality, and their incidence...
A substantial proportion of patients become colonised with Candida spp during hospital stay, but onl...
The number of nosocomial fungal infections is increasing due to several factors, but especially due ...
Fungal diseases are an increasingly recognized cause of mortality worldwide and often pose diagnosti...
Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care...
Recently, the prevalence of invasive fungal infections (IFIs) is rising. The global mortality rate o...
Patient characteristics, antifungal prophylaxis, and other factors appear to have contributed to a c...
The incidence of fungal infections has been increasing for the last 3 decades, especially among neut...
Most fungal infections are common in humans. Pathogenic fungi are opportunistic but can cause fungal...
The aim of this article is to review the current recommendations for the diagnosis and treatment of ...
OBJECTIVE: To describe the incidence and patterns of nosocomial fungal infection in a large teaching...
The steady world-wide increase in the number of severely immunocompromised patients in most hospital...
Introduction: Nosocomial infections due to Candida show significant mortality and morbidity in recen...
Invasive fungus infection affects about six people out of every 100,000 people each year. Only half ...
Invasive fungus infection affects about six people out of every 100,000 people each year. Only half ...
Candidemia and invasive candidiasis are major causes of morbidity and mortality, and their incidence...
A substantial proportion of patients become colonised with Candida spp during hospital stay, but onl...
The number of nosocomial fungal infections is increasing due to several factors, but especially due ...
Fungal diseases are an increasingly recognized cause of mortality worldwide and often pose diagnosti...
Invasive fungal infections (IFIs) are associated with high morbidity and mortality in intensive care...
Recently, the prevalence of invasive fungal infections (IFIs) is rising. The global mortality rate o...
Patient characteristics, antifungal prophylaxis, and other factors appear to have contributed to a c...
The incidence of fungal infections has been increasing for the last 3 decades, especially among neut...